RPGLF (Regent Pacific Group) Net Margin %: -1,980.16% (As of Dec. 2025)


RPGLF Regent Pacific Group Ltd RPGLF
7 GF Score
Price $0.01
! 7 Warning Signs
View Full Analysis

What is Regent Pacific Group Net Margin %?

Regent Pacific Group RPGLF 7 Net Margin % is -1,980.16% as of Dec. 2025. GuruFocus rates RPGLF with a GF Score™ of 7/100. The stock has 7 warning signs investors should review. Among 956 Drug Manufacturers companies, Regent Pacific Group ranks worse than 97.28% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Regent Pacific Group's Net Income for the six months ended in Dec. 2025 was $-2.50 Mil. Regent Pacific Group's Revenue for the six months ended in Dec. 2025 was $0.13 Mil. Therefore, Regent Pacific Group's net margin for the quarter that ended in Dec. 2025 was -1,980.16%.

The historical rank and industry rank for Regent Pacific Group's Net Margin % or its related term are showing as below:

RPGLF' s Net Margin % Range Over the Past 10 Years
Min: -31936.82   Med: -1546.61   Max: -387.15
Current: -1295.7

RPGLF's Net Margin % is ranked worse than
97.28% of 956 companies
in the Drug Manufacturers industry
Industry Median: 5.56 vs RPGLF: -1295.70

Regent Pacific Group  (OTCPK:RPGLF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Regent Pacific Group Net Margin % Related Terms

Regent Pacific Group Net Margin % Historical Data

* Premium members only.

The historical data trend for Regent Pacific Group's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regent Pacific Group Net Margin % Chart

Regent Pacific Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -387.15 -31,953.51 -8,607.90 -623.37 -1,297.52

Regent Pacific Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10,889.83 -2,130.89 -312.25 -934.60 -1,980.16

RPGLF vs ZTS: Net Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Regent Pacific Group's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regent Pacific Group Net Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Regent Pacific Group's Net Margin % distribution charts can be found below:

* The bar in red indicates where Regent Pacific Group's Net Margin % falls into.


RPGLF
7GF Score
Regent Pacific Group Ltd RPGLF
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Regent Pacific Group Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Regent Pacific Group's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-4.71/0.363
=-1,297.52 %

Regent Pacific Group's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-2.495/0.126
=-1,980.16 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -1,980.16% mean?
Regent Pacific Group (RPGLF) has a Net Margin % of -1,980.16% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Regent Pacific Group and its competitors. According to the industry distribution chart, Regent Pacific Group ranks #930 out of 956 companies in the Drug Manufacturers industry, placing it in the top 97.3%.
Is Regent Pacific Group's Net Margin % too high?
Regent Pacific Group's current Net Margin % is -1,980.16%. Based on the distribution chart, Regent Pacific Group ranks #930 out of 956 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Regent Pacific Group has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does Regent Pacific Group's Net Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Regent Pacific Group ranks #930 out of 956 companies for Net Margin %. This places Regent Pacific Group in the lower half of its industry. The industry median Net Margin % is 5.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Regent Pacific Group and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Regent Pacific Group's current Net Margin % is -1,980.16%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regent Pacific Group stock overvalued right now?
Regent Pacific Group (RPGLF) has a current Net Margin % of -1,980.16%. The current Net Margin % is -1,980.16%. Regent Pacific Group's overall GF Score™ is 7/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Regent Pacific Group (RPGLF), the current Net Margin % is -1,980.16% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Regent Pacific Group Business Description

Other Exchanges 00575:Hong KongRPG:Germany
Address 5 Queen\'s Road Central, 8th Floor, Henley Building, Hong Kong, HKG
Regent Pacific Group Ltd is an investment holding company that runs through two segments: Biopharma and Corporate Investment. Its Biopharma segment is engaged in the research, development, manufacturing, marketing, and sales of pharmaceutical products, and it also develops artificial intelligence (AI) systems for the field of biological aging clocks. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The majority of its revenue comes from the Biopharma segment. Geographically, the Europe; U.S.; and Asia Pacific. It derives maximum revenue from Europe.
7GF Score

Get the complete analysis for RPGLF

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.01
Price